Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Asclepix Therapeutics Inc.
Headquarters: Baltimore, MD, United States of America
Website: http://asclepix.com
Year Founded: N/A
Status: Private
BioCentury | Oct 12, 2021
Management Tracks
Novartis’ Baert joins Flagship
Plus: MacKenzie retiring from Pfizer, Ipsen, Ensoma, ChemoCentryx and more
BioCentury | Apr 16, 2021
Finance
April 15 Quick Takes: Co-founded by Springer and Kruse, GPCR play Tectonic raises $80M; plus AltruBio, Rapha, Benchling, BioAge, Amgen
Tectonic Therapeutic Inc. debuted with an $80 million series A round co-led by Vida Ventures, T.A. Springer, and Polaris Partners to discover and develop of GPCR-targeted therapies. Tectonic was
BioCentury | Mar 18, 2021
Management Tracks
Clyburn takes helm as president of Merck’s human health franchise; plus Iovance, Harmony, Shattuck and more
Michael Nally is stepping down as chief marketing officer of human health at Merck & Co. (NYSE:MRK). Frank Clyburn, Merck’s chief commercial officer, human health, will become president of
Items per page:
1 - 3 of 3